Science Explorer Back to mapMap

Most cited papers from Neuroscience Education Institute

What are the most cited papers from Neuroscience Education Institute?

The most cited paper from Neuroscience Education Institute is "A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor" (Stephen M. Stahl, James F. Pradko, Barbara R. Haight et al., 2004), with 497 citations. Next come "The other face of depression, reduced positive affect: the role of catecholamines in causation and cure" (373) and "The many faces of fatigue in major depressive disorder" (289).

Showing 50 of 60 papers. Every paper with more than 37 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor Stephen M. Stahl, James F. Pradko, Barbara R. Haight et al. · The Primary Care Companion For CNS Disorders Open access 13 Aug 2004 497
2 The other face of depression, reduced positive affect: the role of catecholamines in causation and cure David Nutt, Koen Demyttenaere, Zoltán Janka et al. · Journal of Psychopharmacology 18 Oct 2006 373
3 The many faces of fatigue in major depressive disorder Koen Demyttenaere, Jürgen De Fruyt, Stephen M. Stahl · The International Journal of Neuropsychopharmacology Open access Mar 2005 289
4 Serotonergic Drugs for Depression and Beyond Stephen M. Stahl, Clara Lee-Zimmerman, Sylvia Cartwright et al. · Current Drug Targets Apr 2013 272
5 Which comes first: atypical antipsychotic treatment or cardiometabolic risk? Stephen M. Stahl, Laurence Mignon, Jonathan M. Meyer · Acta Psychiatrica Scandinavica Open access 12 Jan 2009 260
6 15 Years of Clinical Experience With Bupropion HCl Maurizio Fava, Augustus John Rush, Michael E. Thase et al. · The Primary Care Companion For CNS Disorders Open access 15 Jun 2005 259
7 L-Methylfolate: A Vitamin for Your Monoamines Stephen M. Stahl · The Journal of Clinical Psychiatry Open access 30 Sep 2008 238
8 Hypoactive Sexual Desire Disorder Irwin Goldstein, Noel N. Kim, Anita H. Clayton et al. · Mayo Clinic Proceedings Open access Dec 2016 231
9 Cariprazine as a treatment across the bipolar I spectrum from depression to mania: mechanism of action and review of clinical data Stephen M. Stahl, Sarah A. Laredo, Debbi Ann Morrissette · Therapeutic Advances in Psychopharmacology Open access 2020 224
10 Anticonvulsants as Anxiolytics, Part 2: Pregabalin and Gabapentin as α2δ Ligands at Voltage-Gated Calcium Channels Stephen M. Stahl · The Journal of Clinical Psychiatry Open access 15 Apr 2004 204
11 Brain circuits determine destiny in depression: a novel approach to the psychopharmacology of wakefulness, fatigue, and executive dysfunction in major depressive disorder. Stephen M. Stahl, Lishu Zhang, Cristina Damatarca et al. · PubMed 2003 203
12 Anticonvulsants and the Relief of Chronic Pain: Pregabalin and Gabapentin as α2δ Ligands at Voltage-Gated Calcium Channels Stephen M. Stahl · The Journal of Clinical Psychiatry 15 May 2004 201
13 A Critical Review of Atypical Antipsychotic Utilization: Comparing Monotherapy with Polypharmacy and Augmentation Stephen M. Stahl, M.J.W. Grady · Current Medicinal Chemistry Feb 2004 186
14 Neurotransmission of cognition, part 3. Mechanism of action of selective NRIs: both dopamine and norepinephrine increase in prefrontal cortex. Stephen M. Stahl · PubMed Mar 2003 180
15 Anticonvulsants as Anxiolytics, Part 1: Tiagabine and Other Anticonvulsants With Actions on GABA Stephen M. Stahl · The Journal of Clinical Psychiatry Open access 15 Mar 2004 178
16 Psychopharmacology of Anticonvulsants: Do All Anticonvulsants Have the Same Mechanism of Action? Stephen M. Stahl · The Journal of Clinical Psychiatry Open access 15 Feb 2004 174
17 The Psychopharmacology of Energy and Fatigue Stephen M. Stahl · The Journal of Clinical Psychiatry Open access 15 Jan 2002 158
18 Guidelines for the recognition and management of mixed depression Stephen M. Stahl, Debbi Ann Morrissette, Gianni L. Faedda et al. · CNS Spectrums Open access 28 Feb 2017 152
19 What Was the Set of Ubiquitin and Ubiquitin-Like Conjugating Enzymes in the Eukaryote Common Ancestor? Caroline Michelle, Patrick Vourc’h, Laurence Mignon et al. · Journal of Molecular Evolution Open access 18 May 2009 151
20 Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression Stephen M. Stahl, Richard Entsuah, Richard L. Rudolph · Biological Psychiatry Dec 2002 149
21 "Dopamine System Stabilizers, Aripiprazole, and the Next Generation of Antipsychotics, Part 1: "Goldilocks" Actions at Dopamine Receptors Stephen M. Stahl · The Journal of Clinical Psychiatry Open access 15 Nov 2001 145
22 Is Psychopharmacologic "Inoculation" Effective in Preventing Posttraumatic Stress Disorder? Stephen M. Stahl · The Journal of Clinical Psychiatry 15 Jan 2005 140
23 Escitalopram in the Treatment of Panic Disorder Stephen M. Stahl, Ivan P. Gergel, Dayong Li · The Journal of Clinical Psychiatry 15 Nov 2003 140
24 Dopamine System Stabilizers, Aripiprazole, and the Next Generation of Antipsychotics, Part 2: Illustrating Their Mechanism of Action Stephen M. Stahl · The Journal of Clinical Psychiatry Open access 15 Dec 2001 136
25 Understanding pain in depression Stephen M. Stahl, Mike Briley · Human Psychopharmacology Clinical and Experimental 20 Sep 2004 128
26 Does Depression Hurt? Stephen M. Stahl · The Journal of Clinical Psychiatry Open access 15 Apr 2002 105
27 The relevance of COVID ‐19 pandemic to psychiatry Donatella Marazziti, Stephen M. Stahl · World Psychiatry Open access 11 May 2020 104
28 Atypical Antipsychotics: Matching Receptor Profile to Individual Patient's Clinical Profile Darius K. Shayegan, Stephen M. Stahl · CNS Spectrums Oct 2004 94
29 A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children Azmi F. Nasser, Tesfaye Liranso, Toyin Adewole et al. · Clinical Therapeutics Open access 25 Jul 2020 85
30 Major Depressive Disorder: Understanding the Significance of Residual Symptoms and Balancing Efficacy with Tolerability Larry Culpepper, Philip R. Muskin, Stephen M. Stahl · The American Journal of Medicine Open access 30 Aug 2015 82
31 “Meta-guidelines” for the management of patients with schizophrenia Stephen M. Stahl, Debbi Ann Morrissette, Leslie Citrome et al. · CNS Spectrums 16 Apr 2013 75
32 Antipsychotic Polypharmacy: Squandering Precious Resources? Stephen M. Stahl · The Journal of Clinical Psychiatry Open access 15 Feb 2002 75
33 Hippocampal nitric oxide upregulation precedes memory loss and Aβ1-40accumulation after chronic brain hypoperfusion in rats J. C. de la Torre, Bruce A. Pappas, Vincent Prévot et al. · Neurological Research Sep 2003 70
34 Clinical outcomes following one-, two-, three-, and four-level anterior cervical discectomy and fusion: a national database study Peter Y. Joo, Justin R. Zhu, Alexander J. Kammien et al. · The Spine Journal 10 Nov 2021 68
35 Modulating the serotonin system in the treatment of major depressive disorder Debbi Ann Morrissette, Stephen M. Stahl · CNS Spectrums Dec 2014 68
36 Comparing rates of early pedicle screw loosening in posterolateral lumbar fusion with and without transforaminal lumbar interbody fusion David H. Kim, Raymond W. Hwang, Gyu-Ho Lee et al. · The Spine Journal 5 May 2020 66
37 Serum Phosphatidylethanolamine and Lysophosphatidylethanolamine Levels Differentiate Alzheimer’s Disease from Controls and Predict Progression from Mild Cognitive Impairment Daniel A. Llano, for the Alzheimer’s Disease Neuroimaging Initiative, Viswanath Devanarayan · Journal of Alzheimer s Disease 26 Jan 2021 65
38 Mechanism of Action of α2δ Ligands: Voltage Sensitive Calcium Channel (VSCC) Modulators Stephen M. Stahl · The Journal of Clinical Psychiatry 15 Aug 2004 64
39 Does hearing loss lead to dementia? A review of the literature Yosra Nadhimi, Daniel A. Llano · Hearing Research Open access 30 Jul 2020 62
40 Fibromyalgia—pathways and neurotransmitters Stephen M. Stahl · Human Psychopharmacology Clinical and Experimental 28 May 2009 60
41 The Psychopharmacology of Painful Physical Symptoms in Depression Stephen M. Stahl · The Journal of Clinical Psychiatry 15 May 2002 60
42 A Temperature-sensitive Mutation of Crygs in the Murine Opj Cataract Debasish Sinha, M. Keith Wyatt, Robert Sarra et al. · Journal of Biological Chemistry Open access Mar 2001 58
43 Once-Daily SPN-812 200 and 400 mg in the treatment of ADHD in School-aged Children: A Phase III Randomized, Controlled Trial Azmi F. Nasser, Tesfaye Liranso, Toyin Adewole et al. · Clinical Therapeutics Open access 6 Mar 2021 55
44 TRPV1 Antagonists and Chronic Pain: Beyond Thermal Perception Michael R. Brandt, Chad E. Beyer, Stephen M. Stahl · Pharmaceuticals Open access 2 Feb 2012 55
45 High-Cost Use of Second-Generation Antipsychotics Under California's Medicaid Program Stephen M. Stahl, Meghan M. Grady · Psychiatric Services 2006 54
46 Differences in mechanism of action between current and future antidepressants. Stephen M. Stahl, Meghan M. Grady · PubMed 2003 54
47 Antidepressant Treatment of Psychotic Major Depression: Potential Role of the σ Receptor Stephen M. Stahl · CNS Spectrums Apr 2005 53
48 Practical guide for prescribing MAOIs: debunking myths and removing barriers Meghan M. Grady, Stephen M. Stahl · CNS Spectrums 26 Apr 2012 53
49 Anticonvulsants as Mood Stabilizers and Adjuncts to Antipsychotics: Valproate, Lamotrigine, Carbamazepine, Oxcarbazepine and Actions at Voltage-Gated Sodium Channels Stephen M. Stahl · The Journal of Clinical Psychiatry Open access 15 Jun 2004 52
50 Neurotransmission of Cognition, Part 2: Selective NRIs Are Smart Drugs: Exploiting Regionally Selective Actionson Both Dopamine and Norepinephrineto Enhance Cognition Stephen M. Stahl · The Journal of Clinical Psychiatry Open access 15 Feb 2003 49

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.